18483651. Tricyclic Compounds and their Uses simplified abstract (Novartis AG)

Tricyclic Compounds and their Uses

Organization Name

Novartis AG

Inventor(s)

Vincent Bordas of Village-Neuf (FR)

Markus Furegati of Allschwil (CH)

Jacques Hamon of Habsheim (FR)

Jürgen Hans-Hermann Hinrichs of Schopfheim (DE)

Ziyue Hong of Shanghai (CN)

Fabio Lima of Saint Louis (FR)

Fatma Limam of Strasbourg (FR)

Henrik Moebitz of Arlesheim (CH)

Sandro Nocito of Wölflinswil (CH)

Niko Schmiedeberg of Riehen (CH)

Joseph Schoepfer of Riehen (CH)

Ross Sinclair Strang of Hagenthal le Bas (FR)

Frédéric Zecri of Brookline MA (US)

Huangchao Yu of Suzhou (CN)

Yong Zhang of Suzhou (CN)

Xinkan Yang of Suzhou (CN)

Sisi Zhang of Suzhou (CN)

Wei Li of Suzhou (CN)

Tricyclic Compounds and their Uses - A simplified explanation of the abstract

This abstract first appeared for US patent application 18483651 titled 'Tricyclic Compounds and their Uses

The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I).

• • Key Features and Innovation:**
• The invention introduces a novel compound or salt with potential pharmaceutical applications.
• The formula (I) represents a unique chemical structure that may have therapeutic benefits.
• This innovation opens up possibilities for new drug development and treatment options.

• • Potential Applications:**

The compound or salt could be explored for use in various medical treatments, such as in the pharmaceutical industry for developing new drugs.

• • Problems Solved:**

This technology addresses the need for novel compounds or salts that could potentially lead to the development of effective pharmaceutical products.

• • Benefits:**
• The invention may contribute to advancements in the field of medicine and drug discovery.
• It offers the potential for improved treatment options for various medical conditions.

• • Commercial Applications:**

The compound or salt could have commercial applications in the pharmaceutical industry, leading to the development of new drugs and potential market opportunities.

• • Questions about the Compound or Salt:**

1. What specific medical conditions could this compound or salt potentially treat? 2. How does the chemical structure of formula (I) differ from existing compounds in the pharmaceutical industry?

• • Frequently Updated Research:**

Researchers may continue to explore the potential therapeutic applications of the compound or salt, leading to further advancements in drug development.

Original Abstract Submitted

The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I):